Emulsi Biotech raises $680K Pre-seed (Sweden, Jun 2026)

$680K
640k euro

Reach the investors backing rounds like this

Backed by BSV Ventures, Almi Invest · verified emails and LinkedIn on Datapile

Find your investors →
Generated social card
Emulsi Biotech social card
Headline

Emulsi Biotech secures 640k euro for oral drug delivery - n24.com.tr

About

Emulsi Biotech is a biotechnology firm based in Lund, Sweden, focused on developing a lipid-based platform for the oral delivery of biological medicines. The company aims to address the challenges of administering biological therapies, which typically require injections due to degradation in the gastrointestinal tract.

Article summary

Emulsi Biotech secures 640k euro for oral drug delivery  n24.com.tr

Founder
Eimantas Gladkauskas
CEO and co-founder
Investors · 2
BSV VenturesLead
FUND
Almi Invest
FUND
Related rounds
Aug 25, 2026Solace Care$2.3MPre-seedSweden
Aug 25, 2026eComID$15.6MSweden
Aug 23, 2026Eyedentity$1.4MSeedSweden
Aug 19, 2026Millow$2.1MSweden

4,295 investors back startups in Sweden

You just read who funded Emulsi Biotech. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.

Free account: 5 investor contact unlocks a month, no card required.

About the investors in Sweden